New generic antiretrovirals products: abacavir + lamivudine tablets and nevirapine prolonged-release tablets (2016)

Kivexa® and Viramune® are antiretroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infection in adults, adolescents, and children. A number of generic products have been recently launched for the originator products, Kivexa® and Viramune® 400mg prolonged-release tablets.  This bulletin summarises the new generic products: abacavir + lamivudine tablets and nevirapine prolonged-release tablets and compares the products to their reference product.

NOTE: The content of this resource has not been updated since the publication date. Some information may be out of date and links to other documents or website may not work.

AbacavirAbacavir + LamivudineInfection and infectious diseasesLamivudineNevirapinePatent Expiries

Attachments